Targeting Glycolytic Reprogramming by TsRNA-0032 for Treating Pathological Lymphangiogenesis

Overview

Journal Cell Death Dis

Date 2025 Jan 27

PMID 39870617

Authors

Fan Ye

Ziran Zhang

Lianjun Shi

Shuting Lu

Xiumiao Li

Wan Mu

Qin Jiang

Biao Yan

Affiliations

Soon will be listed here.

Abstract

Lymphangiogenesis is vital for tissue fluid homeostasis, immune function, and lipid absorption. Abnormal lymphangiogenesis has been implicated in several diseases such as cancers, inflammatory, and autoimmune diseases. In this study, we elucidate the role of tsRNA-0032 in lymphangiogenesis and its molecular mechanism. tsRNA-0032 expression is significantly decreased in corneal suture model and human lymphatic endothelial cell (HLEC) model under inflammatory condition. Overexpression of tsRNA-0032 exerts anti-lymphangiogenic effects by inhibiting HLEC proliferation, migration, and tube formation. Moreover, overexpression of tsRNA-0032 inhibits suture-induced corneal lymphangiogenesis. tsRNA-0032 is mainly located in the cytoplasm and interacts with Ago2 protein. Overexpression of tsRNA-0032 reduces ATP production and decreases pyruvate and lactate levels by targeting PKM2, a key enzyme in glycolysis. This regulation of glycolysis alters cellular energy and metabolic balance in HLECs, contributing to anti-lymphangiogenic effects. Clinical data reveals that tsRNA-0032 levels are significantly reduced in corneal tissues of transplant recipients compared to donors, while PKM2 expression is elevated, highlighting the clinical relevance of tsRNA-0032/PKM2 axis in corneal lymphangiogenesis. This study offers new insights into the regulation of lymphangiogenesis and presents potential therapeutic targets for lymphangiogenesis-related diseases.

References

Zong T, Yang Y, Zhao H, Li L, Liu M, Fu X . tsRNAs: Novel small molecules from cell function and regulatory mechanism to therapeutic targets. Cell Prolif. 2021; 54(3):e12977. PMC: 7941233. DOI: 10.1111/cpr.12977. View

Lim L, Bui H, Farrelly O, Yang J, Li L, Enis D . Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC. Blood. 2019; 134(20):1764-1775. PMC: 6856989. DOI: 10.1182/blood.2019001736. View

Calne R, Collier D, Lim S, Pollard S, Samaan A, White D . Rapamycin for immunosuppression in organ allografting. Lancet. 1989; 2(8656):227. DOI: 10.1016/s0140-6736(89)90417-0. View

Guo C, He J, Song X, Tan L, Wang M, Jiang P . Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res. 2019; 149:104463. DOI: 10.1016/j.phrs.2019.104463. View

Vegran F, Boidot R, Michiels C, Sonveaux P, Feron O . Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 2011; 71(7):2550-60. DOI: 10.1158/0008-5472.CAN-10-2828. View

Li K, Lin Y, Luo Y, Xiong X, Wang L, Durante K . A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Mol Cancer. 2022; 21(1):21. PMC: 8764835. DOI: 10.1186/s12943-022-01499-8. View

Li Z, Antila S, Nurmi H, Chilov D, Korhonen E, Fang S . Blockade of VEGFR3 signaling leads to functional impairment of dural lymphatic vessels without affecting autoimmune neuroinflammation. Sci Immunol. 2023; 8(82):eabq0375. DOI: 10.1126/sciimmunol.abq0375. View

Zhao Y, Li X, Ye C, Huang C, Lv X, Li J . The biogenesis, mechanism and function of the tRNA-derived small RNA (tsRNA): a review compared with microRNA. Am J Cancer Res. 2023; 13(5):1656-1666. PMC: 10244104. View

Liang Y, Kong L, Zhang Y, Zhang Y, Shi M, Huang J . Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration. Theranostics. 2024; 14(4):1500-1516. PMC: 10879880. DOI: 10.7150/thno.92943. View

10.

Lee H, Lee S, Lee D . Corneal Lymphangiogenesis: Current Pathophysiological Understandings and Its Functional Role in Ocular Surface Disease. Int J Mol Sci. 2021; 22(21). PMC: 8583961. DOI: 10.3390/ijms222111628. View

11.

Yamakawa M, Doh S, Santosa S, Montana M, Qin E, Kong H . Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. Med Res Rev. 2018; 38(6):1769-1798. PMC: 6135718. DOI: 10.1002/med.21496. View

12.

Zhang Z, Deng X, Liu Y, Liu Y, Sun L, Chen F . PKM2, function and expression and regulation. Cell Biosci. 2019; 9:52. PMC: 6595688. DOI: 10.1186/s13578-019-0317-8. View

13.

Riedel A, Helal M, Pedro L, Swietlik J, Shorthouse D, Schmitz W . Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma. Cancer Immunol Res. 2022; 10(4):482-497. PMC: 7612582. DOI: 10.1158/2326-6066.CIR-21-0778. View

14.

Rossi A, Rigotto G, Valente G, Giorgio V, Basso E, Filadi R . Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer's Disease-Related Models. Cell Rep. 2020; 30(7):2332-2348.e10. DOI: 10.1016/j.celrep.2020.01.060. View

15.

Cai J, Li C, Liu S, Tan M, Sun Y, Sun X . Angiogenin-mediated tsRNAs control inflammation and metabolic disorder by regulating NLRP3 inflammasome. Cell Death Differ. 2024; 31(8):1057-1069. PMC: 11303556. DOI: 10.1038/s41418-024-01311-8. View

16.

Oliver G, Kipnis J, Randolph G, Harvey N . The Lymphatic Vasculature in the 21 Century: Novel Functional Roles in Homeostasis and Disease. Cell. 2020; 182(2):270-296. PMC: 7392116. DOI: 10.1016/j.cell.2020.06.039. View

17.

Schwager S, Detmar M . Inflammation and Lymphatic Function. Front Immunol. 2019; 10:308. PMC: 6399417. DOI: 10.3389/fimmu.2019.00308. View

18.

Dieterich L, Tacconi C, Ducoli L, Detmar M . Lymphatic vessels in cancer. Physiol Rev. 2022; 102(4):1837-1879. DOI: 10.1152/physrev.00039.2021. View

19.

Makinen T, Boon L, Vikkula M, Alitalo K . Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies. Circ Res. 2021; 129(1):136-154. DOI: 10.1161/CIRCRESAHA.121.318142. View

20.

Chen Q, Zhang X, Shi J, Yan M, Zhou T . Origins and evolving functionalities of tRNA-derived small RNAs. Trends Biochem Sci. 2021; 46(10):790-804. PMC: 8448906. DOI: 10.1016/j.tibs.2021.05.001. View